CollaGenex Pharmaceuticals to Hold Conference Call On Atrix Laboratories Marketing Agreement At 11:00 a.m.Business Editors/Health & Medical Writers NEWTOWN, Pa.--(BUSINESS WIRE)--August 27, 2001 CollaGenex Pharmaceuticals, Inc. (Nasdaq:CGPI CGPI Corporate Goods Price Index (Japan) CGPI Capital Goods Price Index (New Zealand) ), announced that it will hold a conference call today at 11:00 a.m. Eastern Time to discuss the Company's licensing and marketing agreement with Atrix Laboratories. The call can be accessed by dialing 800/553-0349 in the U.S. or 612/332-0820 internationally and/or via the Internet through www.collagenex.com or www.streetevents.com. A replay of the call will be available beginning at 2:00 p.m. on August 27, 2001 through September 17, 2001 at 11:59 p.m. by dialing 800/475-6701 in the U.S. or 320/365-3844 internationally and entering Access Code: 601125. The conference call will also be available for replay on both websites for a period of 90 days. About the Company CollaGenex Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on providing innovative medical therapies to the dental market. The company's lead product, Periostat(R), was approved by the FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. in September 1998 and is the first and only pharmaceutical to treat periodontal disease Periodontal Disease Definition Periodontal diseases are a group of diseases that affect the tissues that support and anchor the teeth. Left untreated, periodontal disease results in the destruction of the gums, alveolar bone (the part of the jaws where by inhibiting in·hib·it tr.v. in·hib·it·ed, in·hib·it·ing, in·hib·its 1. To hold back; restrain. See Synonyms at restrain. 2. To prohibit; forbid. 3. the enzymes that destroy periodontal periodontal /peri·odon·tal/ (per?e-o-don´t'l) 1. pertaining to the periodontal ligament or periodontium. 2. near or around a tooth. per·i·o·don·tal adj. 1. support tissues. Periostat is marketed to the dental community by CollaGenex through a professional pharmaceutical sales force composed of approximately 120 sales representatives and managers. Currently, the company's dental sales force is also marketing Vioxx(R), a Merck & Co. drug that the company co-promotes for the treatment of acute dental pain, and Dentaplex(TM), a unique formulation formulation /for·mu·la·tion/ (for?mu-la´shun) the act or product of formulating. American Law Institute Formulation of vitamins and mineral supplements developed by CollaGenex and MediNiche, Inc. to promote oral health. To receive additional information on the Company, please visit our Web site at www.collagenex.com, which is not a part of this press release. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion